Sign in
4

Changes in Ownership

Ovid Therapeutics Inc. Filed Acc 0001209191-21-029041

Options or other derivatives

  • Chief Commercial Officer acquired 44,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tardio Jason · Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +44,000 44,000 D
Loading xslF345X03/doc4.xml…